Shanghai Biochip Co., Ltd. was established in August 2001. The company's existing shareholders: Shanghai Technology Venture Capital (Group) Co., Ltd., Shanghai Zhangjiang (Group) Co., Ltd., Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences Institute, Fudan University, Shanghai Jiaotong University, Shanghai Yidian (Group) Co., Ltd., Ruijin Hospital, Shanghai Jiaotong University School of Medicine, and Shanghai Boxing Gene Chip Co., Ltd. In February 2003, the National Development and Reform Commission approved Shanghai Biochip Co., Ltd. to construct and operate the "Biochip Shanghai National Engineering Research Center" project and officially named it, with a total investment of 290 million yuan. The company (center) is located in the biomedical industry base of Zhangjiang Hi-Tech Park in Pudong, Shanghai. It covers a total area of 40,000 square meters, with a construction area of over 20,000 square meters, and currently has more than 300 employees.
According to the National Development and Reform Commission's requirements for the construction of the "Shanghai National Engineering Research Center of Biochips" project and the company's development strategy, the corporatized National Engineering Research Center is committed to the application of biochips in the fields of life science research, healthcare and drug development. Through more than ten years of construction and development, we have established a technology innovation service system with biological sample resource banks, tissue chips, gene expression profiling chips, and sequencing as core platforms, and focused on molecular medical diagnostic technology and product development and production. Competitive industrialization system, forming three main businesses of scientific research and drug research and development technology services, molecular medical testing services and molecular diagnostic product development and production sales. The company (center) has entered a benign development track of scientific research and cooperation, product research and development, production and sales, and technical services, as well as international cooperation and talent exchange training. It has the ability to innovate independently, compete in the market, and contribute to industry services.
The company (center) adheres to the values of "scientific research and innovation, market orientation, and people-oriented", and in accordance with the requirements of the National Engineering Research Center's construction goals, strives to make the company a collection of technological innovation, achievement transformation, comprehensive services, and personnel training. An advanced level national biochip industrialization base; building the company into an industry benchmarking scientific and technological innovation enterprise with international advanced level and independent research and development capabilities, accelerating Shanghai's goal of becoming a science and technology innovation center with global influence, and serving as China's biomedical field Contributions to technological innovation and industrialization.
Copyright © Shanghai Biochip Co., Ltd.
Address: No. 151 Li Bing Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai
Scan to view
WeChat public account